research use only

Nicastrin Antibody [H21H1]

Cat.No.: F0849

    Application: Reactivity:
    • F0849-wb
      Lane 1: Hela, Lane 2: 3T3, Lane 3: C6, Lane 4: COS-7

    Usage Information

    Dilution
    1:1000
    1:50
    1:200
    Application
    WB, IP, IF
    Reactivity
    Human, Mouse, Rat, Monkey
    Source
    Rabbit Monoclonal Antibody
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW
    110 kDa, 120 kDa
    Positive Control Mouse cerebellum; Mouse retina; Mouse liver; Mouse small intestine; HeLa cells; 3T3 cells; C6 cells; COS-7 cells
    Negative Control

    Datasheet & SDS

    Biological Description

    Specificity
    Nicastrin Antibody [H21H1] detects endogenous levels of total Nicastrin protein.
    Clone
    H21H1
    Synonym(s)
    NCSTN; Nicastrin; KIAA0253; UNQ1874/PRO4317
    Background
    Nicastrin is an essential type I transmembrane glycoprotein and a core subunit of the γ-secretase complex, acting as the substrate receptor that recognizes and presents ectodomain-shed stubs of proteins like APP and Notch for intramembrane cleavage, which generates signaling peptides such as amyloid-β and the Notch intracellular domain implicated in Alzheimer's disease and developmental processes. It features a large, heavily glycosylated extracellular domain with a central β-sandwich core stabilized by disulfide bonds, a dynamic N-terminal lobe containing a substrate-binding pocket (including key residues in the DYIGS motif that capture free N-termini after ectodomain shedding), a single C-terminal transmembrane helix that interacts with presenilin, Aph1, and Pen2 to form the horseshoe-shaped γ-secretase complex, and a short cytoplasmic tail. The extracellular domain of nicastrin binds short hydrophilic N-terminal stubs of substrates through electrostatic interactions, positioning their transmembrane segments precisely above presenilin's catalytic aspartate residues for sequential γ-cleavage, while also stabilizing complex assembly and directing its trafficking to plasma and endosomal membranes. Mutations that disrupt the extracellular binding pocket can abolish substrate recognition without affecting complex formation.
    References
    • https://pubmed.ncbi.nlm.nih.gov/16096062/
    • https://pubmed.ncbi.nlm.nih.gov/25565961/

    Tech Support

    Handling Instructions

    Tel: +1-832-582-8158 Ext:3

    If you have any other enquiries, please leave a message.